Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Brexafemme
Pharma
Scynexis says GSK on hook for $10M after trial starts back up
Scynexis has resumed a trial of Brexafemme, triggering a $10M milestone payment from GSK and another $20 million due in six months, Scynexis says.
Kevin Dunleavy
May 28, 2025 11:54am
FDA lifts 19-month clinical hold on Brexafemme
May 16, 2025 11:18am
GSK amends deal with Scynexis amid Brexafemme manufacturing woes
Jan 3, 2024 11:44am
Scynexis to out license sole commercial med and cut sales team
Oct 20, 2022 3:45pm
Synexis' new data may broaden reach of game-changing Brexafemme
Apr 22, 2022 11:06am
Even during pandemic, FDA approvals remain on a rapid pace
Jul 6, 2021 11:27am
